MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company

The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news